JADA + WADA — peptide bans for Japanese tested athletes
The Japan Anti-Doping Agency (JADA) implements the World Anti-Doping Code in Japan and administers the JADA Anti-Doping Code aligned with the WADA Prohibited List. Japanese athletes in tested sports — sumo, baseball (NPB), soccer (J-League), Olympic disciplines — face JADA-administered testing under the WADA framework. Research peptides fall under WADA S0 (non-approved substances) and are prohibited at all times. BPC-157 is named explicitly since 2022. This article documents the JADA framework and its overlap with PMDA / Japan Customs.
JADA was established in 2001 to implement WADA-aligned anti-doping in Japan. JADA operates under the Sport Basic Act (Spotsu Kihonpo) and the Japanese Sport Council. The JADA Anti-Doping Code mirrors the World Anti-Doping Code, with the WADA Prohibited List 2026 fully adopted. Japanese athletes in JADA-tested sports — Olympic disciplines, professional baseball (NPB), professional soccer (J-League), sumo, athletics, swimming, cycling — face JADA-administered testing.
For research peptides specifically, the same WADA categories apply in Japan as in any WADA-aligned country. Research peptides fall under S0 (non-approved substances) — prohibited at all times, in-competition and out-of-competition. BPC-157 was specified by name in the 2022 WADA Prohibited List update; the JADA Code reflects the named-substance posture. TB-500, Epithalon, Selank, Semax, and GHK-Cu (injectable form) fall under S0 by the catch-all language.
Growth-hormone secretagogues (CJC-1295, Tesamorelin, Sermorelin, Ipamorelin) fall under S2.5 — Growth Hormone Releasing Factors and analogues — not S0. Insulin-mimetics like Tirzepatide and Semaglutide that are approved as drugs are not in S0 but can fall under S4 (hormone modulators) depending on use context. Melanotan family (PT-141, Melanotan II) are not on the List but should be checked annually.
JADA enforcement of S0 in Japanese sports has been less visible than USADA / SIA enforcement but is consistent with the WADA framework. NPB has had multiple individual cases over the past decade. Sumo has had isolated cases, mostly involving foreign-born rikishi. Olympic-discipline cases have followed standard WADA procedures. JADA testing volume is significant — estimated 6,000–8,000 tests per year across all sports.
The JADA / Japan Customs intelligence-sharing framework is more developed than in some other countries. Japan Customs notifications to PMDA for intercepted peptide shipments can flow to JADA when the shipper is a tested athlete. The Whereabouts data JADA collects on tested athletes (under the WADA Code's Whereabouts requirements) makes such cross-references straightforward. An athlete with a recent intercepted peptide order in their package history and a positive test would face a stronger case in their hearing.
Therapeutic Use Exemptions (TUEs) under JADA follow the standard WADA TUE framework. Substances with legitimate medical use can receive exemption when alternatives are not available. Research peptides almost never qualify because they are not approved therapeutic substances in Japan or elsewhere — there is no recognised medical use to grant exemption against. TUEs are common for pharmaceuticals; rare to non-existent for research peptides.
For non-tested athletes — recreational, amateur, weekend warrior — JADA does not test you and WADA rules do not apply. The PMD Act / Japan Customs framework still applies regardless of sport status. Most Japanese biohacker and amateur-athlete peptide use happens in this category.
15-amino-acid peptide derived from a protective protein in gastric juice. Most-researched peptide in the vendor market.
Synthetic fragment of thymosin beta-4. Actively researched for soft-tissue repair.
Russian heptapeptide derived from tuftsin. Anxiolytic/nootropic research.
ACTH(4-10) analog. Investigated for cognitive and neuroprotective effects.
Ala-Glu-Asp-Gly tetrapeptide. Researched for circadian and telomere biology.
Gly-His-Lys copper complex. Researched for skin repair and mitochondrial function.
✓Pros
- JADA framework is well-documented; testing policies and consequences are predictable
- TUE process exists for legitimate medical exemption (rare for research peptides)
- Athlete education is mandatory — registration includes anti-doping briefing
×Cons
- BPC-157 named explicitly since 2022 — was the most-traded peptide pre-listing
- S0 catch-all covers other research peptides without listing
- JADA / PMDA / Japan Customs intelligence-sharing means customs interception can surface in anti-doping records
- 2-year ban for first S0 offence regardless of intent or substance amount
Which Japanese sports does JADA test?
Olympic disciplines, NPB (Nippon Professional Baseball), J-League (soccer), sumo, professional athletics, swimming, cycling, and others. Major leagues conduct year-round in-competition and out-of-competition testing. Lower-tier sports have less consistent programs.
What sanctions apply for a research peptide positive?
2-year ban for first offence under WADA S0; up to 4 years for aggravated cases. The athlete forfeits results, prizes, and rankings from the test date. JADA framework follows the WADA Code precisely.
Has JADA sanctioned peptide-positive athletes?
Yes, including in NPB, sumo, and Olympic disciplines. Specific cases are not always public; JADA publishes annual reports with anonymized statistics. The cumulative sanction count over the past decade is in the dozens, with peptide cases a small share of overall doping cases.
Can I get a TUE for BPC-157?
Almost certainly not. TUEs require the substance to have a legitimate medical use — meaning approval as a therapeutic good somewhere with established clinical guidelines. Research peptides like BPC-157 are not approved as therapeutic goods anywhere, so there is no recognised medical use to grant exemption against.
Does JADA share data with Japan Customs / PMDA?
Yes — under inter-agency arrangements. A Japan Customs interception of a research peptide order does not automatically trigger a JADA investigation, but it can surface in anti-doping cases as evidence if the athlete subsequently tests positive. The Whereabouts data JADA collects on tested athletes makes such cross-references straightforward.
What if I am a non-tested amateur — does JADA care?
JADA does not test or have jurisdiction over non-tested athletes. WADA rules do not apply to you. The PMD Act / Japan Customs framework still applies regardless of sport status — that is the relevant regulatory framework for non-tested users.